S. Bhattacharya

发表

Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether Analog

B. Bednarz, Qianqian Zhao, D. Baiu, 2017, The Journal of Nuclear Medicine.

Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastoma.

Sorabh Singhal, J. Eickhoff, D. Baiu, 2015, American journal of cancer research.

HuR mRNA Ligands Expressed After Seizure

T. Sutula, J. Malter, F. Gourronc, 2005, Journal of neuropathology and experimental neurology.

Y Box-Binding Factor Promotes Eosinophil Survival by Stabilizing Granulocyte-Macrophage Colony-Stimulating Factor mRNA1

S. Esnault, J. Malter, E. Capowski, 2001, The Journal of Immunology.

Serum and low-density lipoprotein enhance interleukin-8 secretion by airway epithelial cells.

W. Busse, J. Gern, J. Malter, 2003, American journal of respiratory cell and molecular biology.

Clinical Benefit Rate and Time to Response in RIBBON-1, a Randomized, Double-Blind, Phase III Trial of Chemotherapy with or without Bevacizumab (B) for the First-Line Treatment of HER2-Negative Locally Recurrent or Metastatic Breast Cancer (MBC).

E. Perez, N. Robert, J. O’Shaughnessy, 2009 .

Comparison of Subgroup Analyses of PFS from Three Phase III Studies of Bevacizumab in Combination with Chemotherapy in Patients with HER2-Negative Metastatic Breast Cancer (MBC).

D. Miles, J. O’Shaughnessy, V. Diéras, 2009 .

Granulocyte macrophage colony-stimulating factor and interleukin-5 activate STAT5 and induce CIS1 mRNA in human peripheral blood eosinophils.

M. Bates, J. Malter, B. A. Stout, 2001, American journal of respiratory cell and molecular biology.

Simultaneous determination of paclitaxel and lansoprazole in rat plasma by LC-MS/MS method and its application to a preclinical pharmacokinetic study of investigational PTX-LAN-PLGA nanoformulation.

T. Pal, J. Khanam, S. Bhattacharya, 2019, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Application of statistical design to evaluate critical process parameters and optimize formulation technique of polymeric nanoparticles

T. Pal, S. Bhattacharya, P. Sarkar, 2019, Royal Society Open Science.

Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.

J. Kuo, A. Polans, P. Clark, 2017, Journal of neurosurgery.

1 α-Hydroxyvitamin D2 inhibits growth of human neuroblastoma

Amol D. Kulkarni, M. Lindstrom, D. Albert, 2007, Journal of Neuro-Oncology.

Natural products induce a G protein-mediated calcium pathway activating p53 in cancer cells.

A. Polans, J. Kenealey, S. Bhattacharya, 2015, Toxicology and applied pharmacology.

Identification of AUF-1 ligands reveals vast diversity of early response gene mRNAs.

T. Giordano, J. Malter, G. Brewer, 1999, Nucleic acids research.

Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction.

M. Lindstrom, D. Albert, L. Subramanian, 2008, Investigative ophthalmology & visual science.

Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB

A. Polans, S. Bhattacharya, S. Darjatmoko, 2011, Melanoma research.

Resveratrol: Challenges in Translation to the Clinic — A Critical Discussion

L. Subramanian, A. Polans, Lalita Subramanian, 2010, Clinical Cancer Research.

Ca2+ binding to EF hands 1 and 3 is essential for the interaction of apoptosis-linked gene-2 with Alix/AIP1 in ocular melanoma.

Krzysztof Palczewski, Saswati Bhattacharya, J. Cox, 2004, Biochemistry.

A chemotherapeutic approach targeting the acidic tumor microenvironment: combination of a proton pump inhibitor and paclitaxel for statistically optimized nanotherapeutics

T. Pal, J. Khanam, S. Bhattacharya, 2018, RSC advances.

Application of statistical design to evaluate critical process parameters and optimize formulation technique of polymeric nanoparticles

T. Pal, S. Bhattacharya, P. Sarkar, 2019, Royal Society Open Science.

1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma.

Amol D. Kulkarni, M. Lindstrom, D. Albert, 2007, Journal of neuro-oncology.